Follow
Christopher R. Lucas
Christopher R. Lucas
Research Scientist, The Ohio State University
Verified email at osu.edu
Title
Cited by
Cited by
Year
Daunorubicin‐loaded DNA origami nanostructures circumvent drug‐resistance mechanisms in a leukemia model
PD Halley, CR Lucas, EM McWilliams, MJ Webber, RA Patton, C Kural, ...
Small 12 (3), 308-320, 2016
2172016
Cruciferous vegetables, isothiocyanates, and bladder cancer prevention
B Abbaoui, CR Lucas, KM Riedl, SK Clinton, A Mortazavi
Molecular nutrition & food research 62 (18), 1800079, 2018
1512018
Probing nucleosome stability with a DNA origami nanocaliper
JV Le, Y Luo, MA Darcy, CR Lucas, MF Goodwin, MG Poirier, CE Castro
ACS nano 10 (7), 7073-7084, 2016
1082016
Engineering cell surface function with DNA origami
E Akbari, MY Mollica, CR Lucas, SM Bushman, RA Patton, ...
Advanced Materials 29 (46), 1703632, 2017
1012017
The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer
B Abbaoui, KH Telu, CR Lucas, JM Thomas-Ahner, SJ Schwartz, ...
Journal of proteomics 156, 94-103, 2017
652017
DNA origami: folded DNA‐nanodevices that can direct and interpret cell behavior
CJ Kearney, CR Lucas, FJ O'Brien, CE Castro
Advanced Materials 28 (27), 5509-5524, 2016
642016
Anti–BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib
EM McWilliams, CR Lucas, T Chen, BK Harrington, R Wasmuth, ...
Blood advances 3 (3), 447-460, 2019
552019
Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes
CR Lucas, HM Cordero-Nieves, RS Erbe, JW McAlees, S Bhatia, ...
The Journal of Immunology 190 (2), 723-736, 2013
482013
DNA origami nanostructures elicit dose‐dependent immunogenicity and are nontoxic up to high doses In vivo
CR Lucas, PD Halley, AA Chowdury, BK Harrington, L Beaver, ...
Small 18 (26), 2108063, 2022
392022
Multiplexed Detection of Molecular Interactions with DNA Origami Engineered Cells in 3D Collagen Matrices
CEC Melika Shahhosseini, Peter E. Beshay, Ehsan Akbari, Niksa Roki ...
ACS Applied Materials and Interfaces, 2022
12022
Evaluating Toxicology, Immunogenicity, Bio-Distribution, and Pharmacokinetics of DNA Origami Nanostructures In Vivo
CR Lucas, P Halley, A Chowdhury, A Lakshmanan, BK Harrington, ...
2019 AIChE Annual Meeting, 2019
2019
Characterization of Nucleosomes using DNA Origami
JV Le, Y Luo, CR Lucas, MG Poirier, CE Castro
Biophysical Journal 110 (3), 501a-502a, 2016
2016
Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes (42.5)
C Lucas, H Cordero-Nieves, K Campbell, S Bhatia, R Hodes, V Sanders
The Journal of Immunology 188 (1_Supplement), 42.5-42.5, 2012
2012
A study of the proximal CD86-induced signaling mechanism that regulates IgG1 production by a B cell
CR Lucas
The Ohio State University, 2012
2012
Prohibitins and the cytoplasmic domain of CD86 are necessary to mediate signaling in B lymphocytes (109.8)
C Lucas, K Campbell, S Bhatia, R Hodes, V Sanders
The Journal of Immunology 186 (1_Supplement), 109.8-109.8, 2011
2011
155. Prohibitins and the cytoplasmic domain of CD86 are necessary to mediate CD86 signaling in B lymphocytes
CR Lucas, VM Sanders
Brain Behavior and Immunity, S223-S224, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–16